The growing incidence and prevalence of chronic and infectious diseases generate high demand for novel therapeutics. Globally, around 8% of the population is affected by rare diseases. In addition, the COVID-19 pandemic significantly impacted the overall market of biopharmaceutical production. Manufacturers in different regions, along with local governments, are increasingly seeking new...